dr. Renée Bultijnck (PhD)
Postdoctoral researcher Department of Radiotherapy and Experimental Cancer Research, Faculty of Medicine and Health Sciences, Ghent University Belgium
(Principal Investigator: prof. Piet Ost)
Research focus
Our research team focuses on the role of rehabilitation interventions (e.g. exercise, nutrition, psychosocial care, medical screenings) in men with prostate cancer and the development and implementation of patient-reported outcome measures (PROMs) in trials and clinical practice.
More specifically, we are engaged in the following research studies.
- Development and validation of HRQoL questionnaire in prostate cancer (EORTC QLQ-PR25)
- PK-PEP: implementatie en evaluatie van een online home-based gezondheidsbevorderend patiënt empowerment programma voor mannen met prostaatkanker (collaboration with Canada)
- TACTIC project: Tailored Activity during and after treatment In Cancer patients
- Sexuality and intimacy care in men with prostate cancer
Furthermore, I am also involved as a quality of life expert in several EORTC QLG studies and international multicentric (clinical) trials.
Biography
- Postdoctoral researcher, Ghent University, Faculty of Medicine and health sciences, Department of Radiotherapy and Experimental Cancer Research (2022-current)
- EORTC QoL Liaison officer DOG GUCG (2024-current)
- EORTC ECI fellowship, School of Cancer and Pharmaceutical Studies, King’s College London, UK, research group Transforming Cancer Outcomes through Research (TOUR)(10/2024 until 03/2025)
- PhD Fellowship of Research Foundation Flanders (FWO), Ghent University, Faculty of Medicine and health sciences, Department of Radiotherapy and Experimental Cancer Research (2017-2022)
- PhD Fellowship, Sydney University, Survivorship Research Group and Centre for Medical Psychology & Evidence-based Decision-making (2019-2020
- Scientific assistant, Ghent University, Faculty of Medicine and health sciences, Department of Radiotherapy and Experimental Cancer Research (2014-2017)
- Master of Science in Health Education and Health Promotion at Ghent University (2012-2014)
- Bachelor in nutrition and dietetics at the college of higher education Ghent (2009-2012)
Key publications
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort. Clin Transl Radiat Oncol. 2023 Dec 29;45:100715.
Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial. World journal of urology. 2021;39(2):357-64.
Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer. BJU international. 2018;121(4):610-8.
A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer. Cancers. 2020;12(1):132.
Contact & links
Lab address: Department of Radiotherapy and Experimental Cancer Research, Corneel Heymanslaan 10; B-9000 Gent
Member of REPOS (Research and Expertise Group for Psychosocial Oncology and Survivorship)
Renée Bultijnck is interested to receive invitations for presentations or talks